Central serous retinopathy associated with topical oral corticosteroid use: a case report.


Journal

Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382

Informations de publication

Date de publication:
02 Jul 2019
Historique:
received: 03 12 2018
accepted: 04 06 2019
entrez: 3 7 2019
pubmed: 3 7 2019
medline: 16 1 2020
Statut: epublish

Résumé

Oral topical corticosteroid gels are widely used in dental medicine. Case studies of central serous retinopathy have been reported following administration of corticosteroids, but none so far coinciding with the use of topical fluocinonide gel. This case report further contributes to the database of potential risks of corticosteroid use. A 40-year-old South Asian woman presented with decreased vision, pigment epithelial detachments, and serous retinal detachments in both eyes 1 month after starting treatment with topical fluocinonide 0.05%, a topical oral corticosteroid gel. Her condition resolved 6 months after discontinuing the use of the steroid. To the best of our knowledge, this is the first case of idiopathic central serous retinopathy associated with the use of oral fluocinonide gel. Discontinuing the use of the steroid may result in resolution of the serous retinal detachment and improvement of visual symptoms. Patients and their doctors who prescribe this medication should be aware of this association.

Sections du résumé

BACKGROUND BACKGROUND
Oral topical corticosteroid gels are widely used in dental medicine. Case studies of central serous retinopathy have been reported following administration of corticosteroids, but none so far coinciding with the use of topical fluocinonide gel. This case report further contributes to the database of potential risks of corticosteroid use.
CASE PRESENTATION METHODS
A 40-year-old South Asian woman presented with decreased vision, pigment epithelial detachments, and serous retinal detachments in both eyes 1 month after starting treatment with topical fluocinonide 0.05%, a topical oral corticosteroid gel. Her condition resolved 6 months after discontinuing the use of the steroid.
CONCLUSIONS CONCLUSIONS
To the best of our knowledge, this is the first case of idiopathic central serous retinopathy associated with the use of oral fluocinonide gel. Discontinuing the use of the steroid may result in resolution of the serous retinal detachment and improvement of visual symptoms. Patients and their doctors who prescribe this medication should be aware of this association.

Identifiants

pubmed: 31262360
doi: 10.1186/s13256-019-2143-3
pii: 10.1186/s13256-019-2143-3
pmc: PMC6604175
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Gels 0
Fluocinonide 2W4A77YPAN

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

201

Références

Indian J Ophthalmol. 1998 Sep;46(3):131-7
pubmed: 10085624
Retina. 2000;20(1):98-9
pubmed: 10696758
Ophthalmology. 2002 Oct;109(10):1834-7
pubmed: 12359603
Surv Ophthalmol. 2002 Sep-Oct;47(5):431-48
pubmed: 12431693
Eur J Ophthalmol. 1992 Jul-Sep;2(3):103-14
pubmed: 1450655
Arch Ophthalmol. 2004 May;122(5):784-6
pubmed: 15136332
Retina. 2004 Jun;24(3):471-4
pubmed: 15187679
Arch Ophthalmol. 2004 Jun;122(6):926-8
pubmed: 15197074
Indian J Ophthalmol. 2005 Jun;53(2):132-4
pubmed: 15976473
Retina. 2007 Nov-Dec;27(9):1168-73
pubmed: 18046220
Retina. 2010 May;30(5):733-8
pubmed: 20168271
Graefes Arch Clin Exp Ophthalmol. 2011 Jul;249(7):969-74
pubmed: 21140161
J Drugs Dermatol. 2011 Aug;10(8):918-21
pubmed: 21818516
J Oral Pathol Med. 2012 Mar;41(3):255-60
pubmed: 21950548
Oral Surg Oral Med Oral Pathol. 1990 Jun;69(6):688-93
pubmed: 2356081
Retina. 2015 Dec;35(12):2505-15
pubmed: 26017871
J Dermatolog Treat. 2016 Oct;27(5):425-6
pubmed: 26822912
Indian J Dent Res. 2018 Jan-Feb;29(1):107-108
pubmed: 29442094
Int J Retina Vitreous. 2018 Sep 19;4:33
pubmed: 30250750
Retina. 1987 Summer;7(2):111-31
pubmed: 3306853
Doc Ophthalmol. 1985 Aug 15;60(1):37-44
pubmed: 4042815
Ann Surg. 1973 Feb;177(2):222-7
pubmed: 4572787
Am J Ophthalmol. 1974 Feb;77(2):158-60
pubmed: 4855826
Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977 May-Jun;83(3 Pt 1):456-67
pubmed: 888264
Graefes Arch Clin Exp Ophthalmol. 1997 Jun;235(6):339-44
pubmed: 9202960
Ophthalmology. 1997 Oct;104(10):1653-60
pubmed: 9331207
Retina. 1998;18(5):479-81
pubmed: 9801050

Auteurs

Preston O'Brien (P)

Austin Retina Associates, 801 W. 38th St., Suite 200, Austin, TX, 78705, USA. pobrien@austinretina.com.

Ryan C Young (RC)

Austin Retina Associates, 801 W. 38th St., Suite 200, Austin, TX, 78705, USA. ryoung@austinretina.com.
Department of Surgery and Perioperative Care, Dell Medical School, University of Texas, Austin, USA. ryoung@austinretina.com.

Shelley Day Ghafoori (SD)

Austin Retina Associates, 801 W. 38th St., Suite 200, Austin, TX, 78705, USA. sday@austinretina.com.
Department of Surgery and Perioperative Care, Dell Medical School, University of Texas, Austin, USA. sday@austinretina.com.

C Armitage Harper (CA)

Austin Retina Associates, 801 W. 38th St., Suite 200, Austin, TX, 78705, USA. charper@austinretina.com.
Department of Surgery and Perioperative Care, Dell Medical School, University of Texas, Austin, USA. charper@austinretina.com.

Robert W Wong (RW)

Austin Retina Associates, 801 W. 38th St., Suite 200, Austin, TX, 78705, USA. rwong@austinretina.com.
Department of Surgery and Perioperative Care, Dell Medical School, University of Texas, Austin, USA. rwong@austinretina.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH